L305-1219 Screening compound: N-cyclohexyl-2-(morpholine-4-carbonyl)-3-oxo-3,4-dihydro-2H-1,4-benzothiazine-6-sulfonamide

L305-1219 Screening compound: N-cyclohexyl-2-(morpholine-4-carbonyl)-3-oxo-3,4-dihydro-2H-1,4-benzothiazine-6-sulfonamide
L305-1219 Screening compound: N-cyclohexyl-2-(morpholine-4-carbonyl)-3-oxo-3,4-dihydro-2H-1,4-benzothiazine-6-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L305-1219
N-cyclohexyl-2-(morpholine-4-carbonyl)-3-oxo-3,4-dihydro-2H-1,4-benzothiazine-6-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L305-1219

Molecular Formula

C19H25N3O5S2 (C19 H25 N3 O5 S2)

Compound Name

N-cyclohexyl-2-(morpholine-4-carbonyl)-3-oxo-3,4-dihydro-2H-1,4-benzothiazine-6-sulfonamide

IUPAC name

N-cyclohexyl-2-(morpholine-4-carbonyl)-3-oxo-34-dihydro-2H-14-benzothiazine-6-sulfonamide

SMILES

O=C(C1Sc(ccc(S(NC2CCCCC2)(=O)=O)c2)c2NC1=O)N1CCOCC1

InChI

InChI=1S/C19H25N3O5S2/c23-18-17(19(24)22-8-10-27-11-9-22)28-16-7-6-14(12-15(16)20-18)29(25,26)21-13-4-2-1-3-5-13/h6-7,12-13,17,21H,1-5,8-11H2,(H,20,23)/t17-/m0/s1

InChI Key

WTHBIBZKNFMBTO-KRWDZBQOSA-N

MDL Number (MFCD)

MFCD27243212

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

439.56

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.063

Distribution Coefficient, logD

2.063

Water Solubility, LogSw

-2.86

Polar Surface Area

91.370

Acid Dissociation Constant (pKa)

11.02

Base Dissociation Constant (pKb)

-3.05

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

57.90

L305-1219 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

GPCR Targeted Library (31838 compounds)

KRAS-Targeted Library (16000 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L305-1219 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L305-1219?
Check Price and Availability of L305-1219, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L305-1219 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L305-1219
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L305-1219
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L305-1219 available by request